| 000 | 01331 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514073120.0 | ||
| 264 | 0 | _c20040511 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1538-4101 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Andrea, Alan D | |
| 245 | 0 | 0 |
_aThe Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _c |
||
| 300 |
_a290-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aChromosomal Instability _xphysiology |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 |
_aDNA Repair _xphysiology |
| 650 | 0 | 4 |
_aFanconi Anemia _xdrug therapy |
| 650 | 0 | 4 | _aFanconi Anemia Complementation Group F Protein |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistone Acetyltransferases |
| 650 | 0 | 4 | _aHistone Chaperones |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 2 _gno. 4 _gp. 290-2 |
|
| 999 |
_c12632081 _d12632081 |
||